Yes! Studies have shown that this therapy can have a positive impact on cardiovascular health by reducing the risk of major adverse cardiovascular events, such as heart attack and stroke. This makes Semaglutide therapy a promising treatment option for patients with type 2 diabetes who are at risk for cardiovascular disease.